Management

Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals highlights that the COVID-19 crisis has opened a window of opportunity…

Industry stakeholders share their views and concerns about the challenges and impact of the coronavirus pandemic and the…

Ravi Mathur, CEO, GS1 India talks about GS1’s initiatives for the pharma sector and the impact its aims to create, in an exclusive…

Express Pharma series on the key pillars of a strategic framework to tackle zoonotic diseases

Dealing with hampered production and lack of input raw materials, AGI glaspac has put in measures to cushion the blow. For…

Reji K Joseph, Associate Professor at Institute for Studies in Industrial Development, New Delhi writes about how different bodies…

Dr Vikram Munshi, Founder and Principal Consultant, Whitespace Consulting and Capability Building, evaluates the state of Jan…

Both China and the US are key markets for India from the pharma industry perspective It’s been more than a year since China and…

The interim results demonstrated prolonged event-free survival in Type 1 SMA patients who received the therapy as well as…

At approximately 40 per cent of the cost of the innovator, Emcure Pharma’s Eribilin is definitely a more cost effective alternate…